Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.52 |
| ▸ | PARP1 | P09874 | 1/20 | 0.51 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.44 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.44 |
| ▸ | GRM5 | P41594 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17806504 | 0.86 | MEN1 (0.50) | DRD2MEN1KMT2ADDB1CRBN | |
| SCHEMBL21938967 | 0.84 | PARP1 (0.46) | DRD2PARP1PARP10HTR2AHTR2C | |
| SCHEMBL30609592 | 0.79 | DRD2 (0.53) | DRD2PARP1PARP10MEN1KMT2A | |
| SCHEMBL2386047 | 0.77 | MEN1 (0.54) | DRD2HTR2AMEN1KMT2ADDB1 | |
| SCHEMBL12038178 | 0.77 | MEN1 (0.54) | PARP1PARP10HTR2AHTR2CHTR2B | |
| SCHEMBL2625800 | 0.77 | NOTUM (0.49) | DRD2PARP1PARP10HTR2AHTR2C | |
| SCHEMBL30561539 | 0.77 | MEN1 (0.54) | DRD2HTR2AMEN1KMT2ADDB1 | |
| SCHEMBL797558 | 0.76 | HTR2A (0.41) | DRD2PARP1PARP10HTR2AHTR2C | |
| SCHEMBL29407570 | 0.76 | MEN1 (0.53) | PARP1PARP10MEN1KMT2ADDB1 | |
| SCHEMBL2016126 | 0.76 | MEN1 (0.53) | PARP1PARP10MEN1KMT2ADDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2627648-A1 | 17aHYDROXYLASE/C17,20-LYASE INHIBITORS | Novartis AG (CH) | 2013-08-21 | — | — | EP | disclosed |
| WO-2012035078-A1 | 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS | NOVARTIS AG (CH) | 2012-03-22 | — | — | WO | disclosed |